Sega EI et al. - This review focuses on recent advances in the use of the vitamin folic acid to target PET agents, gamma-emitters, MRI contrast agents and fluorescent dyes to FR+ cancers for the purpose of diagnosing and imaging malignant masses with improved specificity and sensitivity.